These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12553591)

  • 1. Lack of benefit of intravenous synthetic human secretin in the treatment of autism.
    Molloy CA; Manning-Courtney P; Swayne S; Bean J; Brown JM; Murray DS; Kinsman AM; Brasington M; Ulrich CD
    J Autism Dev Disord; 2002 Dec; 32(6):545-51. PubMed ID: 12553591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.
    Lightdale JR; Hayer C; Duer A; Lind-White C; Jenkins S; Siegel B; Elliott GR; Heyman MB
    Pediatrics; 2001 Nov; 108(5):E90. PubMed ID: 11694674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin.
    Levy SE; Souders MC; Wray J; Jawad AF; Gallagher PR; Coplan J; Belchic JK; Gerdes M; Mitchell R; Mulberg AE
    Arch Dis Child; 2003 Aug; 88(8):731-6. PubMed ID: 12876177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.
    Corbett B; Khan K; Czapansky-Beilman D; Brady N; Dropik P; Goldman DZ; Delaney K; Sharp H; Mueller I; Shapiro E; Ziegler R
    Clin Pediatr (Phila); 2001 Jun; 40(6):327-31. PubMed ID: 11824175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.
    Sandler AD; Sutton KA; DeWeese J; Girardi MA; Sheppard V; Bodfish JW
    N Engl J Med; 1999 Dec; 341(24):1801-6. PubMed ID: 10588965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.
    Coniglio SJ; Lewis JD; Lang C; Burns TG; Subhani-Siddique R; Weintraub A; Schub H; Holden EW
    J Pediatr; 2001 May; 138(5):649-55. PubMed ID: 11343038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism.
    Unis AS; Munson JA; Rogers SJ; Goldson E; Osterling J; Gabriels R; Abbott RD; Dawson G
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1315-21. PubMed ID: 12410073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of secretin on children with autism: a randomized controlled trial.
    Dunn-Geier J; Ho HH; Auersperg E; Doyle D; Eaves L; Matsuba C; Orrbine E; Pham B; Whiting S
    Dev Med Child Neurol; 2000 Dec; 42(12):796-802. PubMed ID: 11132252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What to measure in autism drug trials.
    Roseman B; Schneider E; Crimmins D; Bostwick H; Visintainer P; Jaskow PA; Accardo P
    J Autism Dev Disord; 2001 Jun; 31(3):361-2. PubMed ID: 11518490
    [No Abstract]   [Full Text] [Related]  

  • 10. Secretin and autism: a two-part clinical investigation.
    Chez MG; Buchanan CP; Bagan BT; Hammer MS; McCarthy KS; Ovrutskaya I; Nowinski CV; Cohen ZS
    J Autism Dev Disord; 2000 Apr; 30(2):87-94. PubMed ID: 10832772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of transdermal secretin on behavior of children with autism.
    Ratliff-Schaub K; Carey T; Reeves GD; Rogers MA
    Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism.
    Owley T; McMahon W; Cook EH; Laulhere T; South M; Mays LZ; Shernoff ES; Lainhart J; Modahl CB; Corsello C; Ozonoff S; Risi S; Lord C; Leventhal BL; Filipek PA
    J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1293-9. PubMed ID: 11699803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of porcine secretin in children with autism and pervasive developmental disorder.
    Kern JK; Van Miller S; Evans PA; Trivedi MH
    J Autism Dev Disord; 2002 Jun; 32(3):153-60. PubMed ID: 12108616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretin and sleep in children with autism.
    Honomichl RD; Goodlin-Jones BL; Burnham MM; Hansen RL; Anders TF
    Child Psychiatry Hum Dev; 2002; 33(2):107-23. PubMed ID: 12462350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children with autistic spectrum disorders. II: parents are unable to distinguish secretin from placebo under double-blind conditions.
    Coplan J; Souders MC; Mulberg AE; Belchic JK; Wray J; Jawad AF; Gallagher PR; Mitchell R; Gerdes M; Levy SE
    Arch Dis Child; 2003 Aug; 88(8):737-9. PubMed ID: 12876178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial.
    Roberts W; Weaver L; Brian J; Bryson S; Emelianova S; Griffiths AM; MacKinnon B; Yim C; Wolpin J; Koren G
    Pediatrics; 2001 May; 107(5):E71. PubMed ID: 11331721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple doses of secretin in the treatment of autism: a controlled study.
    Sponheim E; Oftedal G; Helverschou SB
    Acta Paediatr; 2002; 91(5):540-5. PubMed ID: 12113323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism.
    Carey T; Ratliff-Schaub K; Funk J; Weinle C; Myers M; Jenks J
    J Autism Dev Disord; 2002 Jun; 32(3):161-7. PubMed ID: 12108617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretin as a treatment for autism: a review of the evidence.
    Esch BE; Carr JE
    J Autism Dev Disord; 2004 Oct; 34(5):543-56. PubMed ID: 15628608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous secretin for autism spectrum disorder.
    Williams KW; Wray JJ; Wheeler DM
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003495. PubMed ID: 16034901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.